May 2005
Investment Dealers' Digest;5/30/2005, Vol. 71 Issue 21, p44
Trade Publication
The article presents healthcare-related statistics and various news items associated with investment banking. Able Laboratories Inc., the maker of a generic version of Tylenol with codeine, announced last week it has suspended all manufacturing and shipping because of quality control problems. Federal lawmakers announced legislation to ban convicted sex offenders from getting free Viagra, a drug made by Pfizer, and other drugs for impotence, paid for by Medicaid. The U.S. House passed a bill last Tuesday to expand federal financing for embryonic stem cell research.


Related Articles

  • You Can't Fool All the People ... Bush, Laura // Pharmaceutical Technology;Sep2005, Vol. 29 Issue 9, p18 

    Focuses on the issue confronting generic manufacturer Able Laboratories Inc. for forcing staff to falsify quality control records in the U.S. Changes in the methods of manufacturing processes; Risks of producing poor quality drugs; Services of the company.

  • Legislative Corner.  // Healthcare Traveler;Apr2005, Vol. 12 Issue 10, p8 

    Presents updates on issues and topics related to medical care and law in the U.S. as of April 2005. Support given by U.S. citizens to embryonic stem cell research, according to a survey commissioned by the Civil Society Institute's Results for America project; Information on a legislation...

  • Cloning and consensus: Bill C-6.  // CMAJ: Canadian Medical Association Journal;3/30/2004, Vol. 170 Issue 7, p1069 

    Focuses on the passage of Bill C-6 on embryonic stem cells in Canada. Background on embryo stem cell research in Great Britain and in the U.S.; Reasons for a slow progress of the Canadian legislation concerning reproduce technologies; Oppositions to the passage of the bill.

  • Ship Subsidy Legislation in American History.  // Congressional Digest;Jul22, Vol. 1 Issue 10, p5 

    Focuses on ship subsidy legislation in American history. Tariff and navigation law; Encouragement and protection of manufacturers.

  • The Need for Innovative Logistics Breakthroughs. Shister, Neil // World Trade;Mar2005, Vol. 18 Issue 3, p6 

    Discusses the need for innovative logistics in world trade. Impact of the Six Sigma programs and Lean Manufacturing on the manufacturing industry; Improvement in manufacturing suggested by Whirlpool; Logistics challenges facing shippers.

  • Informed consent in embryonic stem cell research: Are we following basic principles? Caulfield, Timothy; Ogbogu, Ubaka; Isasi, Rosario M. // CMAJ: Canadian Medical Association Journal;6/5/2007, Vol. 176 Issue 12, p1722 

    The authors reflect on the two unresolved consent issues relevant to embryo donation for stem cell research in Canada. They focus on the existing Canadian regulations, highlighting on the rules that forbid treating physician to obtain consent from embryo donors to avoid undue influence and the...

  • China � mission possible. Edmonson, R.G. // JoC Week;4/1/2002, Vol. 3 Issue 13, p23 

    Focuses on the Sino-American talks on the international maritime regulations in China. Move of China to tighten control of the maritime industry; Reference to Decree No. 335; Assessment on the rule-making process in shipping.

  • German parliament backs stem-cell research. Schiermeier, Quirin // Nature;2/7/2002, Vol. 415 Issue 6872, p566 

    Reports on the German Parliament's passage of a legislation which allows researchers to use a limited number of human embryonic stem-cell lines. Concerns of scientists about restrictions in the law; Organizations supporting the law.

  • Stem-cell reverse angers Australian biologists. Dennis, Carina // Nature;3/7/2002, Vol. 416 Issue 6876, p4 

    Reports the reaction of biologists on the plan of the government of banning of human embryonic stem-cell lines in Australia. Use of discarded embryos in stem-cell research; Postponement of the implementation of the agreement to establish rules; Proposals of minister for ageing Kevin Andrews on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics